Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
RESEARCH TOOLSreports
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2026 (Q1)Consensus EPS Forecast
1.02Last Year’s EPS
0.9Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: 7.23%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Neutral
While the company achieved record fiscal 2025 results, strong international growth, and continued e-commerce expansion, it faced challenges in certain product segments and supply chain issues. The positive financial performance and strategic innovation efforts are tempered by ongoing tariff and inflationary pressures.Company Guidance
On the call, Prestige Consumer Healthcare provided guidance for fiscal 2026, forecasting revenues between $1.140 billion and $1.155 billion, reflecting an organic growth of 1% to 2% despite a one-point FX headwind. They anticipate diluted EPS to range from $4.70 to $4.82, representing a growth of 4% to 7% due to higher sales, gross margin expansion, and lower interest expenses. The company expects a gross margin of approximately 56.5%, factoring in a $15 million impact from tariffs but supported by strategic cost savings and potential surgical pricing. Free cash flow is projected to exceed $245 million, enabling continued capital allocation toward M&A, share repurchases, and balance sheet flexibility. The guidance reflects a prudent approach given the ongoing macroeconomic uncertainties and tariff impacts.Record Fiscal 2025 Results
Prestige Consumer Healthcare reported record fiscal 2025 results with net revenue exceeding $1.1 billion, a year-over-year increase of over 1%, and adjusted EPS of $4.52, up approximately 7%.
Strong International Segment Growth
The International segment experienced growth exceeding 5%, with notable performance in Australia driven by the Hydralyte brand.
E-commerce Channel Expansion
E-commerce sales continued to grow at a double-digit rate, now representing high teens as a percentage of total sales.
Successful Innovation and Product Launches
New product launches, such as Hydralyte's new flavors and Monistat's maintain kit, contributed to growth, with innovation being a core strategy.
Capital Allocation and Debt Reduction
The company reduced its leverage ratio to 2.4 times and generated $243 million in free cash flow, while executing share repurchases and debt reduction.
---
PBH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PBH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $81.41 | $87.04 | +6.92% |
Feb 06, 2025 | $76.10 | $87.35 | +14.78% |
Nov 07, 2024 | $77.64 | $80.09 | +3.16% |
Aug 08, 2024 | $67.89 | $66.84 | -1.55% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Prestige Consumer Healthcare (PBH) report earnings?
Prestige Consumer Healthcare (PBH) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Prestige Consumer Healthcare (PBH) earnings time?
Prestige Consumer Healthcare (PBH) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PBH EPS forecast?
PBH EPS forecast for the fiscal quarter 2026 (Q1) is 1.02.
---